MDxHealth (MDXH) Stock Price

MDxHealth Price

Euronext Brussels·CLOSED
0.58
​
Market closed

Over the last 19 years MDxHealth grew revenue by 19.5% annually, reaching 107.88 M USD. For MDxHealth, the net margin of -31.1% is up versus -130.4% a few years ago.

MDxHealth stock price

Access this data via the Eulerpool API

MDxHealth business model & stock analysis

MDxHealth SA is a BE-based company operating in Biotechnology industry. The company is headquartered in Herstal, Liege and currently employs 258 full-time employees. The company went IPO on 2006-06-26. MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The firm's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

Frequently asked questions about MDxHealth

12 analysts currently rate the MDxHealth stock: 9 recommend buying, 3 holding and 0 selling. For 2026, analysts expect MDxHealth to generate revenue of 111.19 M USD and earnings per share of -0.52 USD.

Converted at the current exchange rate, the MDxHealth share trades at 0.51 EUR (0.58 USD).

The MDxHealth share (MDXH) is listed on 4 stock exchanges, including: London (0O8G.L).

The expected revenue of MDxHealth is 111.19 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of MDxHealth is -26.01 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of MDxHealth is currently -1.11. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the MDxHealth stock.

The price-to-sales ratio (P/S) of MDxHealth is currently 0.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the MDxHealth stock.

The Eulerpool Quality Score for MDxHealth is 4/10.

The ISIN of MDxHealth is BE0974461940. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of MDxHealth is MDXH. The ticker symbol is used to trade MDxHealth shares on the stock exchange.

Fair ValueTerminal
0.48 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
296,359.89 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Belgium
Currency
USD
Initial public offering
Jun 26, 2006
ISIN
BE0974461940
Cusip
B5950S113
Market capitalization
29.54 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-1.11
P/Ee 2027
-1.98
P/Ee 2028
-3.64
P/Ee 2029
57.52
P/S
P/Se
0.26
EV/EBIT
—
P/B Ratio
1.99
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-40.38 %
Last updated Oct 10, 2026, 1:12 AM

MDxHealth Peer Group

MDxHealth Ticker

BRUSSELS · MDXH.BREURONEXT · MDXH.BRLONDON · 0O8G.LLONDON STOCK EXCHANGE · 0O8G.L

MDxHealth FIGI

O6C1:GR · BBG000PQ0M50MDXH:US · BBG000VBX3M3MDXH:UA · BBG000VBX511MDXH:UC · BBG000VBX584MDXH:UN · BBG000VBX5G5MDXH:UP · BBG000VBX5S2MDXH:UB · BBG000VBX655MDXH:UM · BBG000VBX6H2MDXH:UX · BBG000VBX753MDXH:UR · BBG000VBX7B6MDXH:UD · BBG000VBX9B2MDXH:UF · BBG000VBX9Y7

All fundamentals and in-depth analysis of MDxHealth

Our stock analysis for MDxHealth stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MDxHealth. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.